ZYME
Zymeworks Inc
Halal Rating :
Last Price
$13.89
Last updated:
Market Cap
-
7D Change
-0.5%
1 Year Change
38.21%
Company Overview
Industries
Exchange
Next Earnings Date
Zymeworks Inc. is a clinical-stage biopharmaceutical company that develops multifunctional biotherapeutics. The company focuses on developing novel, targeted therapies to treat cancer and other serious diseases. Their main platform technologies include their Azymetric™ and ZymeLink™ platforms, which are used to develop various therapeutic candidates.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $16.0m | $50.2m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $19.24m | $62.13m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $10.03m | $47.83m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Zymeworks Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.